Pasithea Therapeutics (Pasithea Therapeutics) Short-Term Capital Lease Obligation : $0.03 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Pasithea Therapeutics Short-Term Capital Lease Obligation?

Pasithea Therapeutics's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.03 Mil.

Pasithea Therapeutics's quarterly Short-Term Capital Lease Obligation declined from Sep. 2023 ($0.17 Mil) to Dec. 2023 ($0.08 Mil) and declined from Dec. 2023 ($0.08 Mil) to Mar. 2024 ($0.03 Mil).

Pasithea Therapeutics's annual Short-Term Capital Lease Obligation increased from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.16 Mil) but then declined from Dec. 2022 ($0.16 Mil) to Dec. 2023 ($0.08 Mil).

Pasithea Therapeutics Short-Term Capital Lease Obligation Historical Data

The historical data trend for Pasithea Therapeutics's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pasithea Therapeutics Short-Term Capital Lease Obligation Chart

Pasithea Therapeutics Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

0.16

0.08

Pasithea Therapeutics Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial										0.17	0.17	0.17	0.08	0.03

Pasithea Therapeutics Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Pasithea Therapeutics Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Pasithea Therapeutics's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Pasithea Therapeutics (Pasithea Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pasithea Therapeutics Corp (NAS:KTTAW) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

KTTA:USA

Address

1111 Lincoln Road, Suite 500, Miami Beach, FL, USA, 33139

Website

https://www.pasithea.com

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders. Epidemiological data indicate neuropsychiatric disorders as being some of the most prevalent, devastating, and yet poorly treated illnesses.